Renaissance Technologies - MOONLAKE IMMUNOTHERAPEUTICS ownership

Back to all holdings Add to watchlist

MOONLAKE IMMUNOTHERAPEUTICS's ticker is and the CUSIP is 61559X104.

Links
Filings
Quarter-by-quarter ownership
Renaissance Technologies ownership history of MOONLAKE IMMUNOTHERAPEUTICS
ValueSharesWeighting
Q3 2023$764
-3.4%
13,396
-13.6%
0.00%0.0%
Q2 2023$791
+62.8%
15,500
-31.7%
0.00%0.0%
Q1 2023$486
+298.4%
22,700
+95.5%
0.00%–
Q4 2022$122–11,609–0.00%–
 Download
Other shareholders

There were no reported owners of MOONLAKE IMMUNOTHERAPEUTICS in Q4 2023.

NameSharesValueWeighting ↓
View complete list of MOONLAKE IMMUNOTHERAPEUTICS shareholders